MedPath

A Questionnaire for Endoscopic Prediction Improvement of Gastrointestinal Cancer

Not Applicable
Conditions
Early Detection of Cancer
Registration Number
NCT04071431
Lead Sponsor
Yanqing Li
Brief Summary

Despite improvements in a range of chemo, radio and surgical therapies, the overall survival at 5 years from gastrointestinal cancer remains poor. Endoscopic early diagnosis is a key strategy to improve survival but the detection rate of early cancer varies among different countries. Risk factor questionnaire result is easy to be obtained and may be of great help for improving the detection rate. The aim of this research is to validate a risk factor questionnaire to help predict gastrointestinal cancer therefore allowing earlier diagnosis and higher detection rate.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
34906
Inclusion Criteria
  • Patients aged more than 18 years with or without GI symptoms attending for endoscopy.
Exclusion Criteria
  • Patients unable to cooperated the endoscopy or unable to complete it. People with endoscopy contraindications are naturally excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rate changeup to 24 months

The endoscopic detection rate change of precancerous lesions and early GI cancer with the help of self-rating RFQ for the prediction of GI cancer.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Gastroenterology, Qilu Hospital, Shandong University

🇨🇳

Jinan, Shandong, China

Department of Gastroenterology, Qilu Hospital, Shandong University
🇨🇳Jinan, Shandong, China
Yanqing Li, PhD. MD.
Contact
18678827666
liyanqing@sdu.edu.cn

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.